2004
DOI: 10.1070/rc2004v073n08abeh000912
|View full text |Cite
|
Sign up to set email alerts
|

Conformationally rigid cyclic α-amino acids in the design of peptidomimetics, peptide models and biologically active compounds

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
28
0

Year Published

2005
2005
2018
2018

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 73 publications
(28 citation statements)
references
References 168 publications
0
28
0
Order By: Relevance
“…Both non-natural amino acids 10a and 11a can be used for synthesis of isomeric peptidomimetics, providing the rigid scaffolds for unusual secondary structure elements. 16 In conclusion, we have developed a practical synthetic procedure leading to functionalized 3-aza-, 3-oxa-, and 3-thiabicyclo[3.3.1]nonanes 1a,b,d-l. The overall yield of the key intermediate products 6a-c is 40%, and these are readily transformed further to generate chemically very diverse libraries of compounds for biological screening.…”
Section: Paper Syn Thesismentioning
confidence: 99%
“…Both non-natural amino acids 10a and 11a can be used for synthesis of isomeric peptidomimetics, providing the rigid scaffolds for unusual secondary structure elements. 16 In conclusion, we have developed a practical synthetic procedure leading to functionalized 3-aza-, 3-oxa-, and 3-thiabicyclo[3.3.1]nonanes 1a,b,d-l. The overall yield of the key intermediate products 6a-c is 40%, and these are readily transformed further to generate chemically very diverse libraries of compounds for biological screening.…”
Section: Paper Syn Thesismentioning
confidence: 99%
“…To date, nearly two dozen isoxazole‐containing pharmaceuticals, including semisynthetic β‐lactam antibiotics (e.g, oxacillin, dicloxacillin, flucloxacillin, and cloxacillin), sulfonamide antibacterials, antidepressants, antirheumatic drugs, anti‐inflammatory agents, antiviral drugs, fungicides, and hypoglycemic agents, have been approved by the FDA (Figure ). The use of conformationally restricted amino acids that contain heterocyclic rings for the preparation of peptidomimetics has recently been explored An interesting application in this field includes our recent reported on the preparation and use of 5‐aminoisoxazole restricted amino acids . This heterocyclic fragment is also present in the molecules of the above‐mentioned sulfonamide antibiotics (e.g., sulfametoxazole, sulfafurazole, and sulfisoxazole) as well as quirzatinib, which is currently under investigation for the treatment of acute myeloid leukemia …”
Section: Introductionmentioning
confidence: 99%
“…In view of the importance of the aforementioned classes of amino acids, the development of pathways to new three-and four-membered azaheterocyclic α-and β-amino acid derivatives is a challenging research field in modern synthetic chemistry at the biological interface (Hughes 2009a;Kiss and Fülöp 2010;Fülöp et al 2006;Kuhl et al 2005;Miller and Nguyen 2005;Cativiela and Ordóñez 2009;Komarov et al 2004;Cowell et al 2004;Gelmi and Pocar 2003;Park and Kurth 2002). Following a preliminary communication (Mangelinckx et al 2008), in the present paper, in-depth results are described on the synthesis and study of the reactivity of 2-(bromomethyl)aziridine-2-carboxylic esters and 3-bromoazetidine-3-carboxylic esters, the structures of which incorporate the synthetically important 2-(halomethyl)aziridine (Abbaspour Tehrani et al 2002;De Smaele et al 1998;De Kimpe et al 1997;D'hooghe et al 2006a;Mangelinckx et al 2009;Vervisch et al 2010), or 3-haloazetidine structural motif (Van Driessche et al 2006;Van Brabandt et al 2009).…”
Section: Introductionmentioning
confidence: 99%